Inhibition of pressure-activated cancer cell adhesion by FAK-derived peptides

Bixi Zeng1,2,3, Dinesh Devadoss1,2, Shouye Wang1

  • 1Department of Surgery, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, United States.

Oncotarget
|December 13, 2017
PubMed

Insights

Blocking FAK-Akt1 interaction with a novel peptide may prevent cancer metastasis during surgery. This targeted approach inhibits tumor cell adhesion and dissemination, offering a safer alternative to broad FAK or AKT inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Surgical Innovation

Background:

  • Cancer metastasis is often potentiated by surgical stress, involving FAK-Akt1 signaling and tumor cell adhesion.
  • Current treatments targeting FAK or AKT can cause systemic toxicity, necessitating more specific interventions.

Purpose of the Study:

  • To investigate if inhibiting FAK-Akt1 interaction can prevent perioperative tumor dissemination.
  • To identify and utilize a specific peptide sequence that disrupts FAK-Akt1 binding.

Main Methods:

  • Serial truncation and mutagenesis of FAK to identify a peptide that competes with Akt1.
  • Adenoviral delivery of the FAK-derived peptide in SW620 colon cancer cells under increased pressure.
  • Assessing cancer cell adhesion to collagen-I and murine surgical wounds.
  • Evaluating tumor-free survival in mice after tumor cell exposure during simulated surgical conditions.

Main Results:

  • The FAK-derived peptide successfully inhibited pressure-induced FAK phosphorylation and FAK-Akt1 co-immunoprecipitation.
  • Adenoviral FAK-derived peptide expression prevented pressure-induced adhesion of SW620 cells to surfaces and surgical wounds.
  • In vivo, the FAK-derived peptide significantly improved tumor-free survival in mice exposed to pressure-treated cancer cells.

Conclusions:

  • Targeting the FAK-Akt1 interaction with a specific peptide can effectively inhibit perioperative tumor cell adhesion and metastasis.
  • This peptide-based strategy offers a promising, targeted approach to reduce cancer spread during surgery without systemic toxicity.
  • Analogs of this 7-amino acid FAK-derived peptide could be developed as novel anti-metastatic therapeutics.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K
Cell Adhesion Molecules - Types and Functions01:20

Cell Adhesion Molecules - Types and Functions

Cell adhesion molecules (CAMs) are pivotal to multicellularity and the coordinated functioning of tissues and organ systems. They enable physical interactions between cells and provide mechanical strength to tissues. They also function as receptors for signal transmission across the plasma membrane. The CAMs are broadly classified into four families - integrins, cadherins, selectins, and immunoglobulin-like CAMs (IgCAMs).
CAM Families
The Integrin family of proteins is primarily  involved...
9.9K
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.2K
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
5.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K